VM Pharma LLC
3Patents
3Active
3Granted
47Portfolio score
Filing activity: Dec 8, 2009 → Apr 18, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8809530B1 | Compositions of protein receptor tyrosine kinase inhibitors | Chemistry; Metallurgy | 32 | Active |
| US8999992B2 | Crystalline forms of tryosine kinase inhibitors and their salts | Emerging Cross-Sectional Technologies | 7 | Active |
| US9040508B2 | Compositions of protein receptor tyrosine kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.